
Universe Pharmaceuticals Inc. (UPC)
UPC Stock Price Chart
Explore Universe Pharmaceuticals Inc. interactive price chart. Choose custom timeframes to analyze UPC price movements and trends.
UPC Company Profile
Discover essential business fundamentals and corporate details for Universe Pharmaceuticals Inc. (UPC) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
23 Mar 2021
Employees
225.00
CEO
Gang Lai
Description
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM). These remedies are designed to address common chronic health issues prevalent among the elderly, promoting physical well-being and longevity, in addition to offering medications for cold and flu symptoms. Beyond its own manufactured goods, UPC also functions as a distributor and vendor for a diverse range of third-party products. This extensive portfolio includes biomedical drugs, medical instruments, traditional Chinese medicine 'pieces' (raw ingredients), and various dietary supplements. Its clientele spans across the healthcare sector, encompassing other pharmaceutical companies, hospitals, clinics, and major drugstore chains. Established in 2019, the company's operations are headquartered in Ji'An, China, and it functions as a subsidiary of Sununion Holding Group Limited.
UPC Financial Timeline
Browse a chronological timeline of Universe Pharmaceuticals Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 22 Apr 2026
Stock split effective on 24 Mar 2025
Shares were split 1 : 40 , changing the number of shares outstanding and the price per share accordingly.
Stock split effective on 18 Nov 2024
Shares were split 1 : 15 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 30 Apr 2024
Earnings released on 9 Feb 2024
Stock split effective on 28 Jul 2023
Shares were split 1 : 6 , changing the number of shares outstanding and the price per share accordingly.
UPC Stock Performance
Access detailed UPC performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.